India
Strand Life Sciences, founded in 2000, is a prominent player in the Biotechnology, Health Care, Information Technology, and Clean Energy sectors, with a mission encapsulated by its slogan: "Personalized Genomics For A Healthier Future". Headquartered in India, with a robust presence in the U.S., the company excels in providing cutting-edge genomics and bioinformatics software and services.
Their flagship solutions, StrandNGS for data analysis and Strandomics for variant classification, are utilized by Fortune 500 Companies, showcasing their industry credibility. The company's interdisciplinary team is a testament to its dedication to excellence in genomics, consisting of experts across fields like computer science, data science, and bioinformatics.
Their most recent funding, a $13.00M Private Equity Round on 08 February 2018, involved investments from HealthQuad, Quadria Capital, and Heritas Venture Fund, underscoring sustained confidence from major investors. With a well-rounded approach, Strand Life Sciences stands poised to continue driving innovation in precision medicine.
